Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

BACKGROUND: Many physicians consider platinum-doublet chemotherapy inappropriate for elderly patients, regardless of their medical fitness. OBJECTIVE: This was a retrospective subgroup analysis of data from a multicenter, randomized, phase III clinical trial evaluating pemetrexed + carboplatin versu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, José Rodrigues, Cheng, Rebecca, Orlando, Mauro, Kim, Joo-Hang, Barraclough, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851706/
https://www.ncbi.nlm.nih.gov/pubmed/24277116
http://dx.doi.org/10.1007/s40268-013-0032-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851706/
https://www.ncbi.nlm.nih.gov/pubmed/24277116
http://dx.doi.org/10.1007/s40268-013-0032-6

Ejemplares similares